Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group.

G Sussman; J Shurman; M R Creed; L S Larsen; T Ferrer-Brechner; D Noll; J Allegra; R Montgomery; D Schreck; E Grafstein

doi:10.1016/s0149-2918(00)80024-7

Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group.

Identifier:nobleid.org/w1/20260515/FBAEC0FD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FBAEC0FD.svg?ark=w1%2F20260515%2FFBAEC0FD)](https://nobleid.org/work/w1/20260515/FBAEC0FD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group.

Identifier:nobleid.org/w1/20260515/FBAEC0FD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FBAEC0FD.svg?ark=w1%2F20260515%2FFBAEC0FD)](https://nobleid.org/work/w1/20260515/FBAEC0FD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work